Osaic Holdings’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,450
| Closed | -$9.1K | – | 7622 |
|
|
2023
Q2 | $9.1K | Hold |
10,450
| – | – | ﹤0.01% | 6019 |
|
|
2023
Q1 | $7.29K | Sell |
10,450
-1,705
| -14% | -$1.38K | ﹤0.01% | 6154 |
|
|
2022
Q4 | $9K | Hold |
12,155
| – | – | ﹤0.01% | 6020 |
|
|
2022
Q3 | $13K | Buy |
12,155
+100
| +0.8% | +$160 | ﹤0.01% | 5895 |
|
|
2022
Q2 | $20K | Buy |
12,055
+589
| +5% | +$1.22K | ﹤0.01% | 5631 |
|
|
2022
Q1 | $181K | Sell |
11,466
-900
| -7% | -$3.15K | ﹤0.01% | 4119 |
|
|
2021
Q4 | $59K | Sell |
12,366
-5,030
| -29% | -$32.5K | ﹤0.01% | 5029 |
|
|
2021
Q3 | $132K | Buy |
17,396
+1,561
| +10% | +$9.99K | ﹤0.01% | 4283 |
|
|
2021
Q2 | $118K | Buy |
15,835
+8,200
| +107% | +$63.2K | ﹤0.01% | 4350 |
|
|
2021
Q1 | $59K | Buy |
7,635
+4,613
| +153% | +$46.1K | ﹤0.01% | 4769 |
|
|
2020
Q4 | $28K | Buy |
3,022
+850
| +39% | +$7.39K | ﹤0.01% | 4961 |
|
|
2020
Q3 | $15K | Buy |
2,172
+500
| +30% | +$3.03K | ﹤0.01% | 5090 |
|
|
2020
Q2 | $11K | Buy |
+1,672
| New | +$6.04K | ﹤0.01% | 5152 |
|
Osaic Holdings's SURF Position: Q3 2023 in Review
Osaic Holdings sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 10,450 shares — an estimated $9.1K sold.
Osaic Holdings first reported a position in SURF in Q2 2020 and held it in 13 quarters. The position peaked at $181K in Q1 2022. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- Osaic Holdings reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Osaic Holdings sold 10,450 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $9.1K.
- Osaic Holdings first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
- Osaic Holdings's Surface Oncology, Inc. Common Stock position peaked at $181K in Q1 2022.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.